Doxercalciferol

This page contains recent news articles, when available, and an overview of Doxercalciferol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Genzyme Corporation - SWOT Analysis - New Report Published  -  ‎Nov 12, 2009‎
Renagel (sevelamer hydrochloride), Hectorol (doxercalciferol), Thyrogen (thyrotropin alfa for injection) and hematologic oncology products. ... OfficialWire (press release)

Calcitriol associated with higher adverse outcomes than doxercalcifero...  -  Nov 10, 2005
In the first analysis, investigators hypothesized that mortality risk would be similar among hemodialysis patients treated with either doxercalciferol or ... Medscape

Genzyme to buy Bone Care for $600M.(Pharmaceutical industry)(Brief …  -  May 16, 2005
Bone Care's Hectorol (doxercalciferol), a line of vitamin D2 pro-hormone products, is used to treat secondary hyperparathyroidism in patients on dialysis, ... $4.95 - Pharma Marketletter - ECNext

血液中å?«é’™é«˜å?¯è‡´å‰?列腺癌  -  Sep 4, 2008
...研究指出,一个简å?•的血液测试就å?¯ç¡®å®šç”·æ€§æ‚£æœ‰æœ€ä¸ºå?±é™©çš„å‰?列腺瘤的机率,并且现在 已有è?¯ç‰©å¦‚å?ˆå??为骨化三醇的罗钙全(calcitriol)ã€?多西骨化醇(doxercalciferol)ã€? ... 环ç?ƒç½‘

FDA Safety Labeling Changes: Hectorol, Mevacor, Pulmicort Respules  -  Sep 28, 2005
If hypercalcemia occurs during therapy, doses of doxercalciferol and/or ... Should hyperphosphatemia occurs, the doxercalciferol dose should be decreased ... Medscape

VITAMIN D AND RELATED COMPOUNDS (Oral route, Parenteral route).( …  -  May 1, 2007
Studies on doxercalciferol or paricalcitol have been done only in adult ... Doxercalciferol or paricalcitol have not been studied in pregnant women. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Vitamin D and Related Compounds (Systemic).(Drug overview)  -  May 1, 2006
Doxercalciferol or paricalcitol have not been studied in pregnant women. ... It is not known whether doxercalciferol or paricalcitol passes into breast milk ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Vitamin D Deficiency and Mortality in Kidney Disease  -  Dec 9, 2008
In animal studies, paricalcitol produces less vascular calcification than doxercalciferol. However, in human observational studies, both doxercalciferol and ... Medscape

Vitamin D and Related Compounds (Systemic).  -  Jul 28, 2005
Doxercalciferol or paricalcitol have not been studied in pregnant women. ... It is not known whether doxercalciferol or paricalcitol passes into breast milk ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Bone Care International, Inc. Reports Third Quarter FY 2005 Financial...  -  Apr 26, 2005
The company reported quarterly sales for Hectorol(R) (doxercalciferol) of $22.0 million, compared to $11.6 million for the third quarter of fiscal 2004, ... $4.95 - PR Newswire - ECNext

Medicare Part D Coverage to Include D-Hormones.  -  May 18, 2005
Hectorol(R) (doxercalciferol) Capsules is a D hormone therapy and will be covered in the Medicare Part D Prescription Drug Program. ... $4.95 - PR Newswire - ECNext

Competitors by Product Report  -  Dec 13, 2008
Hectorol Capsules (Doxercalciferol) ... AMD070 (Chemokine Receptor Inhibitor); FC Receptor 3 Antagonist; GC-1008; Hectorol Capsules (Doxercalciferol) ... $75.00 - Revere Reports - Revere

Competitors by Product Report  -  Dec 13, 2008
Hectorol Capsules (Doxercalciferol) ... AMD070 (Chemokine Receptor Inhibitor); FC Receptor 3 Antagonist; GC-1008; Hectorol Capsules (Doxercalciferol) ... $75.00 - Revere - Alacra Store

Press Release: Bone Care International, Inc. Reports Third Quarter FY...  -  Apr 26, 2005
The company reported quarterly sales for Hectorol(R) (doxercalciferol) of $22.0 million, compared to $11.6 million for the third quarter of fiscal 2004, ... Pay-Per-View - PR Newswire - HighBeam Research

Genzyme Buying Clofarabine Partner In $345M Cash Deal  -  May 30, 2007
Separately, Genzyme Canada Inc. said it reacquired Canadian rights to Hectorol (doxercalciferol) from Shire BioChem Inc. Hectorol is a vitamin D2 hormone ... BioWorld Online - BioWorld Online

Cinacalcet should not be used to treat secondary hyperparathyroidism...  -  Feb 7, 2008
...however, 40% of the cinacalcet group received calcitriol and 10% received doxercalciferol, which is converted, in vivo, to active vitamin D. 11 ... Nature.com

Issues Updates on Genzyme Corp.  -  Jul 12, 2006
The expanded US commercial organization is also helping to drive the growth of Hectorol (doxercalciferol), which treats secondary hyperparathyroidism in ... Free with registration - M2 Presswire - AccessMyLibrary.com

Genzyme Reports Financial Results for the First Quarter of 2006.  -  Apr 19, 2006
Sales of Fabrazyme(R) (agalsidase beta), Synvisc(R) (hylan GF 20) and Hectorol(R) (doxercalciferol) experienced sequential growth below Genzyme's ... Free with registration - PR Newswire - AccessMyLibrary.com

Genzyme Reports Strong Fourth-Quarter Revenue Growth to Conclude …  -  Jan 9, 2007
...and Hectorol® (doxercalciferol), a line of Vitamin D2 products for secondary hyperparathyroidism in dialysis patients and those with earlier stages of ... webwire.com

Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue  -  Jan 9, 2006
Both Renagel and Genzyme's Hectorol® (doxercalciferol) are positioned favorably on most of the Part D prescription drug plans now available to Medicare ... webwire.com

Moderate Renal Dysfunction Linked to Hip Fracture in Older Women  -  Jan 22, 2007
Several active vitamin D compounds, such as calcitriol and Zemplar (paricalcitol), as well as the prohormones alfacalcidol and Hecterol (doxercalciferol) ... MedPage Today

Fresenius to buy US Renal Care  -  May 4, 2005
Bone Care's product Hectorol¿ (doxercalciferol), a line of vitamin D 2 prohormone products, can be used in tandem with Genzyme's Renagel¿ (sevelamer ... Medscape

Vitamin D.  -  Aug 1, 2006
Product Information: Hecterol(R), doxercalciferol. Bone Care International, Inc., Madison, WI, (PI revised 4/2000) reviewed 8/2000. Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com

Medical nutrition therapy when kidney disease meets liver failure.(Iss...  -  Nov 1, 2007
...or paricalcitol given for the control of renal osteodystrophy may also ameliorate CLD-related osteoporosis. Doxercalciferol is not indicated in ESLD as s. Free with registration - Nephrology Nursing Journal - AccessMyLibrary.com

Cytochroma Announces Positive Comparative Data On CTA018 In …  -  Nov 7, 2008
Currently marketed vitamin D hormone replacement therapies (paricalcitol, doxercalciferol and calcitriol) can over-stimulate intestinal absorption of ... Medical News Today - Medical News Today (press release)

Cinacalcet May Improve PTH Control  -  Apr 19, 2007
The ACHIEVE study compared the use of cinacalcet with low-dose vitamin D (paricalcitol/doxercalciferol) and escalating doses of vitamin D alone in the ... Medscape

IV versus PO Vitamin D: the road already traveled.(Controversies in …  -  May 1, 2006
Vitamin D analogues are available in oral form--Rocaltrol (calcitriol) (Roche; Nutley, NJ), Hectorol (doxercalciferol) (Genzyme Corporation, Cambridge, MA), ... Free with registration - Nephrology Nursing Journal - AccessMyLibrary.com

Genzyme to Acquire Bone Care, Adding Complementary Therapy to …  -  May 4, 2005
Bone Care's Hectorol® (doxercalciferol), a line of vitamin D2 pro-hormone products, is used to treat secondary hyperparathyroidism in patients on dialysis, ... Wisbusiness.com

New Insights Into the Effects of Vitamin D Receptor-Activators  -  Jun 9, 2008
Tentori and colleagues [12] examined any VDRA (calcitriol, doxercalciferol, and paricalcitol) vs no treatment in 7731 prevalent HD patients from a single ... Medscape

Genzyme's 3rd-quarter net profit falls 86% on higher costs, despite...  -  Oct 23, 2006
Another of the group's products, Hectorol (doxercalciferol), which is used in the treatment of secondary hyperthyroidism in dialysis patients with ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Renal Function and Risk of Hip and Vertebral Fractures in Older Women  -  Jan 22, 2007
Several active vitamin D compounds, such as calcitriol and paricalcitol, as well as the prohormones alfacalcidol and doxercalciferol have been shown to ... Archives of Internal Medicine

Genzyme's 2nd-qtr net income jumps 4%.(Financial report)(Brief...  -  Aug 6, 2007
Income from Genzyme's phosphate binder, Renagel (sevelamer HCl), rose 14% to $145.0 million, while that from Hectorol (doxercalciferol) jumped 22% to $27.3 ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Genzyme's 2nd-qtr 2006 revenue rises 19%.  -  Jul 24, 2006
...the biotechnology major, expanded its commercial organization in the USA, which it says also helped boost sales of Hectorol (doxercalciferol). ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Genzyme invests another EUR 130m in Irish facility  -  Apr 7, 2008
...the company's doxercalciferol capsule formulation for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD). ... In-PharmaTechnologist.com

Vitamin D.(use to treat hypoparathyroidism, psoriasis, osteoporosis, ...  -  May 1, 2006
Product Information: Hecterol(R), doxercalciferol. Bone Care International, Inc., Madison, WI, (PI revised 4/2000) reviewed 8/2000. Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com

Survival Impact of Vitamin D Therapy in Hemodialysis Patients  -  Jul 17, 2008
...however, showed the same survival advantage for all 3 vitamin D receptor activators used (calcitriol, paricalcitol, and doxercalciferol). ... Medscape

Bone Care International to Present at the Roth Capital Partners 17th ...  -  Feb 15, 2005
Our current commercial and therapeutic focus is in nephrology, utilizing Hectorol(R) (doxercalciferol), our novel vitamin D hormone therapy, ... Free with registration - Business Wire - AccessMyLibrary.com

Draxis buy gets shareholder green light  -  May 26, 2008
Draxis' biggest contract is to make Genzyme's Hectorol (doxercalciferol), used to reduce elevated intact parathyroid hormone (iPTH) levels in the treatment ... OutSourcing-Pharma.com

Merger and Acquisition Scenario  -  Jul 21, 2007
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask; Viasys Pulmonex Pulmonary ... $250.00 - Revere Reports - Revere

How to take Calcitriol from Consumer Reports Health.  -  Jan 4, 2005
...other forms of vitamin D such as calcifediol (Calderol), dihydrotachysterol (Hytakerol, DHT), doxercalciferol (Hectorol), ergocalciferol (Drisdol, ... consumerreports.org

Genzyme Reports Strong Third-Quarter Financial Results.  -  Oct 12, 2006
...and Hectorol(R) (doxercalciferol), a line of Vitamin D2 products for secondary hyperparathyroidism in dialysis patients and those with earlier stages of ... $4.95 - PR Newswire - ECNext

Merger and Acquisition Scenario  -  Aug 4, 2007
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask; Viasys Pulmonex Pulmonary ... $250.00 - Revere Reports - Revere

Food Product Design: Health/Nutrition - July 2005 - Cancer-Fighting …  -  Jul 1, 2005
...trials focus on selenium and vitamin E, with other investigations looking into soy isoflavones, green-tea polyphenols and doxercalciferol. ... Food Product Design

Merger and Acquisition Scenario  -  Dec 29, 2007
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask; Viasys Pulmonex Pulmonary ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Feb 9, 2008
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask; Viasys Pulmonex Pulmonary ... $250.00 - Revere Reports - Revere

Genzyme; Recent developments from Genzyme summarized  -  Dec 12, 2006
Sales of Fabrazyme (agalsidase beta), Synvisc (hylan GF 20) and Hectorol (doxercalciferol) experienced sequential growth below Genzyme's expectations, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

BizTimes Daily for Thursday, June 30, 2005 - BizTimes  -  Jun 30, 2005
...will begin selling two complementary products to nephrologists in the United States: Hectorol (doxercalciferol) and Renagel (sevelamer hydrochloride). ... Milwaukee Small Business Times

Merger and Acquisition Scenario  -  Mar 24, 2007
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Allegiance Nonsterile Guedel Airways; Allegiance Trachea Tubes ... $250.00 - Revere Reports - Revere

Oregon Regulations - 850-060-0226 Naturopathic Formulary by …  -  Feb 1, 2006
...(w) Varicella*; (x) Yellow Fever*; (37) Vitamins**; (a) Calcitonin; (b) Calcitriol; (c) Cyanocobalamin; (d) Doxercalciferol; (e) Leucovorin Calcium; ... Pay-Per-View - Oregon Regulations - Loislaw

Competitors by Product Report  -  Apr 12, 2008
Genzyme Corporation (GENZ) Products:. Hectorol Capsules (Doxercalciferol). GTC Biotherapeutics, Inc. (GTCB) Products:. Transgenic MM-093 (Recombinant Human ... $75.00 - Revere Reports - Revere

Managing ESRD following MI.(Clinical Twisters)(end-stage renal...  -  Jun 20, 2005
...calcitriol could be changed to another vitamin D analog such as paricalcitol (Zemplar, Abbott) or doxercalciferol (Hectorol, Bone Care International). ... Free with registration - Drug Topics - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Jan 20, 2007
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Allegiance Ultra Robertazzi Nasopharyngeal Airways; Allegiance Nonsterile ... $250.00 - Revere Reports - Revere

IV versus PO Vitamin D: the road already traveled.(Controversies in …  -  May 1, 2006
Vitamin D analogues are available in oral form--Rocaltrol (calcitriol) (Roche; Nutley, NJ), Hectorol (doxercalciferol) (Genzyme Corporation, Cambridge, MA), ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research

Merger and Acquisition Scenario  -  Sep 6, 2008
ChloraPrep; Hectorol Capsules (Doxercalciferol); Medical Products and Services; Specialty Pharmaceutical Distribution ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 3, 2007
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask; Viasys Pulmonex Pulmonary ... $250.00 - Revere Reports - Revere

Press Release: Perrigo Company Announces Collaborative Agreement …  -  May 21, 2008
Cobrek all of its interests in current and future ANDA filings including a potential first-to-file on a generic version of Hectorol (Doxercalciferol). ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Nov 18, 2006
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Allegiance Nonsterile Guedel Airways; Allegiance Trachea Tubes ... $250.00 - Revere Reports - Revere

Genzyme Delivers Strong Third-Quarter Results.  -  Oct 18, 2005
Third-quarter prescriptions for Hectorol(R) (doxercalciferol) were on track with expectations. Sales in the quarter were $14.1 million, as Genzyme reduced ... $4.95 - PR Newswire - ECNext

Press Release: Fontus Pharmaceuticals Acquires Nephrology and …  -  Jun 16, 2008
Fontus Pharmaceuticals Incorporated's Rocaltrol, also called calcitriol; Genzyme Corporation's Hectorol (doxercalciferol); Abbott Laboratories ... ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Mar 11, 2006
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Allegiance Nonsterile Guedel Airways; Allegiance Ultra Robertazzi ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 24, 2007
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Allegiance Nonsterile Guedel Airways; Allegiance Trachea Tubes ... $250.00 - Revere Reports - Revere

Genzyme, Bone Care International Announce Shareholder Approval of …  -  Jun 30, 2005
...begin selling two complementary products to nephrologists in the United States: Hectorol(R) (doxercalciferol) and Renagel(R) (sevelamer hydrochloride). ... $4.95 - PR Newswire - ECNext

Finance; Pharmaceutical firm reports fourth consecutive quarter of …  -  Feb 22, 2005
The company reported record quarterly sales for Hectorol (doxercalciferol) of $19.6 million, compared to $9.1 million for the second quarter of fiscal 2004, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Genzyme Reports Second-Quarter GAAP EPS of $0.46, Non-GAAP EPS …  -  Jul 14, 2005
Genzyme expanded its Renal business on July 1 with its acquisition of Bone Care International, a transaction that added Hectorol(R) (doxercalciferol) to the ... $4.95 - PR Newswire - ECNext

Competitors by Product Report  -  Aug 2, 2008
Genzyme Corporation (GENZ) Products:. Hectorol Capsules (Doxercalciferol). GTC Biotherapeutics, Inc. (GTCB) Products:. Transgenic MM-093 (Recombinant Human ... $75.00 - Revere Reports - Revere

Press Release: Genzyme and Bone Care International Announce …  -  Jun 15, 2005
Both Renagel and Genzyme's Hectorol(R) (doxercalciferol ... product were $20 million. Genzyme began marketing Hectorol in ... company's acquisition of Bone ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Jul 12, 2008
Target. ChloraPrep; Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmonex Pulmonary Assist Circuits ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 27, 2008
ChloraPrep; Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask ... $250.00 - Revere Reports - Revere

Finance; Pharmaceutical firm reports fourth consecutive quarter of …  -  Feb 25, 2005
The company reported record quarterly sales for Hectorol (doxercalciferol) of $19.6 million, compared to $9.1 million for the second quarter of fiscal 2004, ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

Perrigo to buyback $30M of its shares over next 12 mths, MedImmune to...  -  Apr 27, 2005
The company reported quarterly sales for Hectorol (doxercalciferol) of $22.0 million, compared to $11.6 million for the third quarter of fiscal 2004, ... $4.95 - M2 Presswire - ECNext

Merger and Acquisition Scenario  -  Oct 25, 2008
ChloraPrep; Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmonex Pulmonary Assist Circuits ... $250.00 - Revere Reports - Revere

Press Release: Genzyme Reports Financial Results for the First...  -  Apr 19, 2006
Sales of Fabrazyme(R) (agalsidase beta), Synvisc(R) (hylan G-F 20) and Hectorol(R) (doxercalciferol) experienced sequential growth below Genzyme's ... Pay-Per-View - PR Newswire - HighBeam Research

Oregon Regulations - 850-060-0225 Naturopathic Formulary …  -  Feb 1, 2006
...(121) DMPS (Board approved certification required before therapeutic IV chelation is allowed); (122) DMSA; (123) Doxercalciferol; (124) Doxycycline; ... Pay-Per-View - Oregon Regulations - Loislaw

Competitors by Product Report  -  Oct 4, 2008
Genzyme Corporation (GENZ) Products:. Hectorol Capsules (Doxercalciferol). GTC Biotherapeutics, Inc. (GTCB) Products:. Transgenic MM-093 (Recombinant Human ... $75.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 8, 2007
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask; Viasys Pulmonex Pulmonary ... $250.00 - Revere Reports - Revere

Bone Care International to Present At Smith Barney Citigroup 2005 …  -  Mar 18, 2005
Our current commercial and therapeutic focus is in nephrology, utilizing Hectorol(R) (doxercalciferol), our novel vitamin D hormone therapy, ... $4.95 - PR Newswire - ECNext

Franklin Capital Corp acquires SurgiCount Medical Inc - Deal Snapshot...  -  Feb 25, 2005
Injection (Doxercalciferol) Healthcare Services Distributors Medical Equipment General Products: Medical Products and Services Specialty Pharmaceutical… ... Pay-Per-View - deals - Alacra Store

Press Release: Medicare Part D Coverage to Include D-Hormones. - PR …  -  May 18, 2005
Hectorol(R) (doxercalciferol) Capsules is a D hormone therapy and will be covered in the Medicare Part D Prescription Drug Program. ... Pay-Per-View - PR Newswire - HighBeam Research

Genzyme guidance upped on good 2nd qtr.(Brief Article)  -  Jul 25, 2005
...million acquisition of Bone Care International (Marketletter July 11), a transaction that added Hectorol (doxercalciferol) to the company's portfolio. ... $4.95 - Pharma Marketletter - ECNext

Florida Administrative Code - 64B16-28.850 Special Pharmacy — ESRD.  -  Jul 5, 2005
...(e) Doxercalciferol. (f) Epoetin Alfa. (g) NACL INJ 50 MEQ/20 ML. (h) Levocarnitine. (i) Lidocaine. (j) Vitamin Preparations (dialysate use only). ... Pay-Per-View - Florida Administrative Code - Loislaw

Bone Care International to Present at Deutsche Bank Health Care …  -  Apr 22, 2005
Our current commercial and therapeutic focus is in nephrology, utilizing Hectorol(R) (doxercalciferol), our novel vitamin D hormone therapy, ... $4.95 - PR Newswire - ECNext

Competitors by Product Report  -  Dec 13, 2008
Genzyme Corporation (GENZ) Products:. AMD070 (Chemokine Receptor Inhibitor); FC Receptor 3 Antagonist; GC-1008; Hectorol Capsules (Doxercalciferol) ... $75.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Oct 18, 2008
ChloraPrep; Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmonex Pulmonary Assist Circuits ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 1, 2008
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask; Viasys Pulmonex Pulmonary ... $250.00 - Revere Reports - Revere

Competitors by Product Report  -  Mar 29, 2008
Genzyme Corporation (GENZ) Products:. AMD070 (Chemokine Receptor Inhibitor); FC Receptor 3 Antagonist; GC-1008; Hectorol Capsules (Doxercalciferol) ... $75.00 - Revere Reports - Revere

Competitors by Product Report  -  Aug 2, 2008
Genzyme Corporation (GENZ) Products:. Hectorol Capsules (Doxercalciferol). GTC Biotherapeutics, Inc. (GTCB) Products:. Transgenic MM-093 (Recombinant Human ... $75.00 - Revere - Alacra Store

Merger and Acquisition Scenario  -  May 3, 2008
Hectorol Capsules (Doxercalciferol); ALARIS Medical Systems A-Line AEP Monitor; Viasys Pulmanex Hi-Ox Disposable Oxygen Mask; Viasys Pulmonex Pulmonary ... $250.00 - Revere Reports - Revere

Press Release: Genzyme, Bone Care International Announce …  -  Jun 30, 2005
...begin selling two complementary products to nephrologists in the United States: Hectorol(R) (doxercalciferol) and Renagel(R) (sevelamer hydrochloride). ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Sep 6, 2008
ChloraPrep; Hectorol Capsules (Doxercalciferol); Medical Products and Services; Specialty Pharmaceutical Distribution ... $250.00 - Revere Reports - Revere

New Jersey Administrative Code - 10:58A-4.3 HCPCS procedure codes …  -  Aug 16, 2005
...dolasetron mesylate, 1 mg 17.32 J1270 Injection, doxercalciferol, 1 mcg 6.03 (Hectorol) J1320 Injection, amitriptyline HCI, (Elavil 2.34 HCI), ... Pay-Per-View - New Jersey Administrative Code - Loislaw

El calcio en la sangre puede revelar cáncer fatal de próstata  -  Sep 4, 2008
...ya existen fármacos que pueden reducir los niveles de calcio en la corriente sanguínea, como el calcitriol, doxercalciferol, paricalcitol y cinacalcet. ... Con Nuestro Peru

Georgia Code - 16-13-71. (a) A "dangerous drug" means any drug other ...  -  Aug 4, 2005
...(318.5) Doxazosin mesylate; (319) Doxepin; (319.5) Doxercalciferol; (320) Doxorubicin; (321) Doxycycline; (322) Doxylamine; (323) Doxylamine succinate; ... Pay-Per-View - Georgia Code - Loislaw





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy